iGMDRD401
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Afatinib | CHEMBL2105712 CHEMBL1173655 | 10184700 | DB08916 | Alone | Small Molecule |
Drug Class:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 InhibitorsBCRP/ABCG2 SubstratesHeterocyclic CompoundsHeterocyclic Compounds, 2-RingKinase InhibitorP-glycoprotein/ABCB1 InhibitorsP-glycoprotein/ABCB1 SubstratesProtein Kinase InhibitorsDrug Pathways:
EGFR signalingDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene ID | Gene Name | Model Num. |
---|---|---|
7514 | XPO1 | 1 |
3845 | KRAS | 5 |
8289 | ARID1A | 2 |
4771 | NF2 | 3 |
2195 | FAT1 | 1 |
5175 | PECAM1 | 1 |
1111 | CHEK1 | 1 |
5605 | MAP2K2 | 1 |
7158 | TP53BP1 | 2 |
55294 | FBXW7 | 2 |
25937 | WWTR1 | 1 |
7428 | VHL | 2 |
2064 | ERBB2 | 31 |
983 | CDK1 | 1 |
6850 | SYK | 1 |
472 | ATM | 2 |
10413 | YAP1 | 1 |
1029 | CDKN2A | 1 |
7157 | TP53 | 1 |
4088 | SMAD3 | 1 |
3673 | ITGA2 | 1 |
6714 | SRC | 1 |
3791 | KDR | 1 |
4436 | MSH2 | 1 |
57111 | RAB25 | 2 |
4089 | SMAD4 | 4 |
54658 | UGT1A1 | 1 |
5290 | PIK3CA | 2 |
675 | BRCA2 | 1 |
1956 | EGFR | 206 |
4609 | MYC | 1 |
5747 | PTK2 | 1 |
673 | BRAF | 4 |
1938 | EEF2 | 1 |
5728 | PTEN | 2 |
8821 | INPP4B | 1 |
2067 | ERCC1 | 1 |
9223 | MAGI1 | 2 |
2194 | FASN | 1 |
5111 | PCNA | 1 |
3717 | JAK2 | 1 |
100862685 | ERVK-19 | 1 |
5894 | RAF1 | 1 |
4893 | NRAS | 1 |
2065 | ERBB3 | 17 |
374 | AREG | 1 |
595 | CCND1 | 1 |
4763 | NF1 | 1 |
3265 | HRAS | 1 |
1499 | CTNNB1 | 1 |
5624 | PROC | 1 |
Gene in drug-gene network: Network Plot
Models in Afatinib